Financial Shenanigans
Financial Shenanigans — Gogoro Inc. (GGR)
The Forensic Verdict
Gogoro screens as Elevated risk on the forensic dimension, but the pattern is one of presentation aggression rather than evidence of accounting fraud. The two concerns that drive the grade are (1) a textbook post-CEO-change "big bath" in FY2024 — $32 million of China/India machinery impairments plus $38.7 million of "other operating expenses" the year founder Horace Luke departed — which mechanically created the FY2025 "narrowed loss" recovery narrative, and (2) a non-IFRS framework that headlines a record $59.9 million adjusted EBITDA against an $80.0 million IFRS net loss while excluding the battery-upgrade derecognition charges that management itself says "will recur in future periods." No restatement, auditor resignation, material weakness, or SEC enforcement has been disclosed, and the heaviest cash-flow lifelines (factoring, payable stretch, supplier finance) are absent — operating cash flow is real, but it is the residual of a $91 million depreciation tail on an aging, impaired capital base. The one disclosure that would move the grade down is a clean auditor opinion on the FY2025 20-F with no emphasis-of-matter on going concern; the one that would move it up is any subsidy-clawback enforcement, Castrol put exercise, or failure of director Yin Chung-Yao to procure the NT$2.5 billion equity package that the company's lenders required as a covenant relaxation.
Forensic Risk Score (0-100)
Red Flags
Yellow Flags
CFO ÷ Net Income (5y)
Adj EBITDA vs IFRS NI Gap ($M, FY25)
Grade: Elevated (58/100). Adjusted EBITDA exceeded IFRS net loss by $140 million in FY2025 — the largest gap in the company's reporting history. The non-IFRS framework excludes battery-upgrade derecognition that management explicitly describes as recurring, share-based compensation that will resume once new awards are granted, and FY2024 big-bath impairments that paved the path for the FY2025 recovery narrative.
Thirteen-Shenanigan Scorecard
Breeding Ground
The governance, audit, and financing setup amplifies — rather than offsets — the accounting-presentation risks elsewhere in the file. Three signals matter most. First, Gold Sino's stake rises from 31.4% to 49.0% once the March 11, 2026 share purchase agreement closes, putting the company one share away from a controlled-company classification, with director Chung-Yao Yin acting as both the Gold Sino affiliate and the chair of the Nominating & Corporate Governance Committee. Second, the audit committee has only two members — Hui-Ming Cheng (13-year board tenure, audit chair since the SPAC merger) and Karen Yifen Chang (appointed May 2025, under one year of seat time). Third, the September 2025 syndicated-loan amendment relaxed covenants in exchange for Mr. Yin's personal undertaking to procure NT$2.5 billion of new equity by December 2026 — turning the company's going-concern viability into a private commitment by a single related party.
Concentration of governance levers. The chair of the Nominating Committee, the procurer of the going-concern equity package, and the affiliate of the largest shareholder are the same person. Independent-director ratification of every Gold Sino capital-raise term — and disclosure of any side letters tied to the NT$2.5 billion undertaking — would meaningfully de-risk this configuration.
Earnings Quality
The income statement passes the most basic revenue test — receivables are tiny in absolute dollars ($18.7 million on $281.5 million of revenue) and DSO drift from 20 to 23 days reflects falling hardware sales rather than channel stuffing. The earnings-quality concern is concentrated in two places: the FY2024 big-bath that preceded FY2025's "recovery," and the gross-margin lift that draws a meaningful share of its expansion from items management classifies as one-time.
Big-bath signature around the September 2024 CEO change
"Other operating expenses" jumped from $3.0 million in FY2023 to $38.7 million in FY2024 (+1177%), driven primarily by $32 million of China/India underutilized-machinery impairments and loss on disposal of property. The timing — within the same fiscal year that founder/CEO Horace Luke stepped down on September 13, 2024 — is the canonical setup for a big bath: a clean-the-decks impairment cycle followed by a "recovery" gross margin in the successor's first full year. Management's own MD&A confirms the mechanical effect: $28.2 million of the FY2025 reduction in operating expenses came from the non-recurrence of FY2024's other-op-exp items.
Gross margin lift is real but partially mechanical
Roughly 4.3 percentage points of the 5.6 pp gross-margin expansion can be quantified from items management characterizes as one-time or program-related (inventory write-down reduction, battery upgrade completion, voluntary rebate non-recurrence, lower SBC). The residual 1.3 pp combines genuinely structural drivers — higher-ASP product mix, overseas restructuring savings, and lower depreciation on the upgraded battery base. The underlying durable improvement is real but smaller than the headline 8.2% suggests.
Capex collapse is the FCF story
Capex fell 47% YoY in FY2025 to $65 million — well below the $91 million depreciation run-rate — while the battery network (over 2,700 GoStations, 665K subscribers) continues to consume the existing fleet. Management frames this as efficiency from the completed battery upgrade program; underwriting requires confirming that FY2026 capex returns to a maintenance level rather than the network entering a deferred-renewal regime.
Cash Flow Quality
Operating cash flow looks better than it did a year ago, but the headline overstates the durability. Net loss is $80 million; CFO is $35.9 million; the bridge is $127 million of non-cash charges ($91M D&A + $17.6M PPE disposal loss + $5.8M impairment + $2.3M SBC + other) minus a $1 million working-capital use. This means almost the entire CFO is the depreciation tail of an impaired capital base — capex is the test of whether that tail is sustainable.
Cumulative FY2019-FY2025: CFO +$148 million, Net income -$508 million, Free cash flow -$732 million. Gogoro has never produced positive free cash flow in any annual period of the public-data set.
Working-capital contribution — not the lifeline
Inventory liquidation contributed $16 million of cash, but trade payables fell by $16.7 million — paying suppliers faster as the business shrinks is a use of cash, not a source. Net working capital was a $1 million use of cash in FY2025 per management's own MD&A. This is unusual for a forensic flag in a positive way: the company is not engineering CFO through aggressive payable stretch or receivable factoring, which are the most common cash-flow shenanigans for a stressed issuer.
Acquisition-adjusted FCF is moot — but disposal-driven add-backs are not
The $17.6 million loss on PPE disposal in FY2025 — five times the FY2024 figure — accelerated as the company exited overseas markets. These are real economic losses that are appropriately added back to derive CFO under IFRS, but they materially flatter the apparent operating-cash-generation profile and should not be projected forward.
Metric Hygiene
This is the loudest forensic signal in the file. Gogoro's FY2025 press release leads with three superlatives: "record" adjusted EBITDA of $59.9 million, "strong non-IFRS profitability," and a CFO figure of $31.1 million (the audited 20-F figure is $35.9M — a $4.8M presentation gap between the press release and filing that should reconcile by the time the full audited statements are released). Under IFRS, FY2025 produced an $80.0 million net loss, an $86.2 million pre-impairment operating loss, and a -$29.1 million free cash flow.
The non-IFRS framework has been expanded twice since FY2022 — battery-upgrade derecognition and customer-care-package adjustments were added as new exclusion categories — and now spans seven separate add-backs. The hygiene table below summarizes the position of each.
The recurring-exclusion contradiction. Page 8 of the FY2025 earnings release defines "Battery Upgrade Initiatives" as an excluded non-IFRS item — and then states verbatim: "We expect the derecognition expense and retrieval and other costs to recur in future periods as incurred during the implementation phase of the battery upgrade program." Excluding admitted-recurring costs from a headline profitability metric is the single clearest non-IFRS shenanigan in the file.
What to Underwrite Next
The forensic risk here is large enough to require an underwriting haircut, but not large enough to break a thesis on its own. The accounting is not fraudulent; the presentation is aggressive and the balance sheet is structurally fragile. Five items deserve quarterly tracking:
Audited FY2025 20-F auditor opinion (filing dated March 31, 2026). Watch for any emphasis-of-matter paragraph on going concern, any qualification on the Castrol put option contingency, or any material-weakness disclosure on internal control over financial reporting given the related-party financing dependency.
Gold Sino post-49% threshold. The next tranche of the NT$2.5 billion equity undertaking will likely push Gold Sino over 50% and trigger NASDAQ controlled-company status, which exempts the board from majority-independence requirements. If that happens, the already-thin audit committee becomes the only structural protection for minority shareholders.
Capex/D&A reversion in FY2026. A capex print under $80 million would extend the deferred-renewal pattern; a print between $90M-$110M would validate the efficiency story. The FY2026 guidance is silent on capex.
Battery-upgrade derecognition charges in 1H 2026. Management says the program is "complete" but also says costs will recur. The first quarter that shows zero battery-upgrade exclusion in the non-IFRS reconciliation will validate the disclosure; any continued exclusion confirms the recurring-cost contradiction.
Castrol put exercise window. Castrol Holdings can require Gogoro to repurchase $25 million of shares through December 31, 2026 if a change of control, uncured material breach, or delisting occurs. The Gold Sino move to 49% raises the change-of-control probability and therefore the put-trigger probability.
A grade downgrade to "Watch" would require: clean auditor opinion with no emphasis-of-matter, completed NT$2.5 billion equity package on disclosed terms, capex restored above D&A, and removal of the battery-upgrade exclusion from non-IFRS. A grade upgrade to "High" would require: a Castrol put exercise, a covenant breach, a material-weakness disclosure, or a Taiwan subsidy clawback materially in excess of the existing accrual.
For position sizing, the accounting risk here is not a footnote — it is a valuation haircut and a sizing limiter, not a thesis breaker. Treat reported adjusted EBITDA at roughly 60% of the headline (strip battery upgrades and a normalized $20M-$25M SBC re-accrual), require capex/D&A above 1.0x to validate the cash-flow narrative, and discount the going-concern resolution to the credibility of one related-party undertaking rather than to standalone financial capacity. The reported numbers are a faithful representation of IFRS reality; the narrative around them stretches more than the accounting does.